Embedded Files
CRAFT YOUR BUSINESS, AND REDEFINE YOUR PERFORMANCE WITH DELVEINSIGHT!
Astrocytoma Market Research Report 2032
The Astrocytoma market is anticipated to increase, due to an increase in the incidence of brain tumors and the anticipated launch of novel therapies.
DelveInsight’s Astrocytoma market report thoroughly explains Astrocytoma, historical and forecasted epidemiology, as well as the Astrocytoma market trends in the 7MM.
Some of the Key Highlights from the Astrocytoma Market Report
According to Crocetti et al., astrocytic tumor incidence rates vary significantly among European areas, ranging from 3/100,000 in Eastern Europe to 5/100,000 in the United Kingdom.
According to the National Organization for Rare Disorders (NORD), Anaplastic astrocytoma and glioblastoma multiforme are expected to affect 5-8 persons per 100,000 in the general population.
Leading players in the Astrocytoma market include Denovo Biopharma, Orbus Therapeutics, Diffusion Pharmaceuticals, and others.
Key Astrocytoma therapies in the pipeline include DB102, Eflornithine, Trans Sodium Crocetinate (TSC), and others.
The US FDA and EMA designated DB102 (Denovo Biopharma) as an orphan drug for DLBCL and glioblastoma multiforme (GBM), and the US FDA granted it Fast Track Designation.
Have queries? Request for the sample @ Astrocytoma Market Outlook
View Report: https://www.delveinsight.com/report-store/astrocytoma-market
Astrocytoma Overview
Astrocytoma is a tumor that can develop in the brain or the spinal cord. It starts in nerve-supporting cells called astrocytes and is the most frequent type of brain tumor in adults. Astrocytoma is classified as grade 1 (most benign) to grade 4 (most malignant) by the World Health Organization (WHO).
Astrocytoma Epidemiology Segmentation
The Astrocytoma report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
Astrocytoma Total Incident Cases
Astrocytoma Grade-Specific Cases
Astrocytoma Total Diagnosed Cases
Astrocytoma Gender-Specific Cases
Astrocytoma Line Wise Treated Cases
Astrocytoma Treatment Landscape
The current Astrocytoma treatment options include:
Surgery
Steroids
Chemotherapy
Radiotherapy
Bevacizumab (Avastin)
Off Label Therapies (Procarbazine hydrochloride)
View Report: https://www.delveinsight.com/report-store/astrocytoma-market
The Astrocytoma market will expand during the forecast period, 2021–2030, due to an increase in the incidence of brain tumors and the anticipated launch of novel therapies such as DB102, Eflornithine, Trans Sodium Crocetinate (TSC), and others.
Discover more about the future market share of the drugs @ Astrocytoma Market Analysis
Astrocytoma Pipeline Therapies and Key Companies
DB102: Denovo Biopharma
Eflornithine: Orbus Therapeutics
Trans Sodium Crocetinate (TSC): Diffusion Pharmaceuticals
View Report: https://www.delveinsight.com/report-store/astrocytoma-market
Table of Contents
1.
Key Insights
2.
Executive Summary of Astrocytoma
3.
SWOT Analysis of Astrocytoma
4.
Astrocytoma: Market Share (%) Distribution Overview at a Glance: By Country
5.
Epidemiology and Market Methodology
6.
Astrocytoma: Disease Background and Overview
7.
Epidemiology and Patient Population
8.
Epidemiology Scenario: 7MM
9.
The United States Epidemiology
10.
EU-5 Epidemiology
11.
Japan Epidemiology
12.
Current Treatment Practices
13.
Unmet Needs
14.
Patient Journey of Astrocytoma
15.
Key Endpoints in Astrocytoma Clinical Trials
16.
Marketed Therapies
17.
Emerging Therapies
18.
Conjoint Analysis of Astrocytoma
19.
Astrocytoma: Eight Major Market Analysis
20.
7MM Market Size
21.
United States Market Size
22.
EU-5 Market Size
23.
Japan Market Size
24.
Market Access and Reimbursement of Astrocytoma Therapies
25.
Market Drivers
26.
Market Barriers
27.
Appendix
28.
DelveInsight Capabilities
29.
Disclaimer
30.
About DelveInsight
DelveInsight’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.
Other Reports:
Related Blogs:
Most Promising Applications of Artificial Intelligence (AI) in Healthcare Segment
Mapping the Biggest Pharmaceutical Companies by Continents
Widespread Usage of HPV Vaccine Reduces Cervical Cancers and Precancers
Major Drugs Decisions for Cardiovascular Diseases to Watch Through 2022
Assessment of Key Products that Got FDA Approval in Second Half (H2) of 2021
Evaluation of Rapidly Evolving Parkinson’s Disease Therapeutic Market
About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Connect With Us at:
Page updated
Report abuse